Neurally Adjusted Ventilatory Assist for Non Invasive Ventilation and Patient-ventilator Interaction
The Effects of Neurally Adjusted Ventilatory Assist (NAVA) on Improving Patient-ventilator Interaction in Patients Undergoing Ventilation for Acute Respiratory Failure
1 other identifier
interventional
13
2 countries
4
Brief Summary
The present study aims to compare various parameters reflecting patient-ventilator synchrony during standard pressure support (PS) and Neurally Adjusted Ventilatory assist (NAVA) in a group of patients receiving non invasive ventilation (NIV)for an episode of acute respiratory failure of various origin.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2010
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 23, 2010
CompletedFirst Posted
Study publicly available on registry
February 24, 2010
CompletedStudy Start
First participant enrolled
July 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2011
CompletedSeptember 21, 2012
January 1, 2010
5 months
February 23, 2010
September 20, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Patient-ventilator synchronization parameters
Study Arms (2)
Pressure support
NO INTERVENTIONNon invasive ventilation under pressure support (PS)
Neurally Adjusted Ventilatory Assist
ACTIVE COMPARATORNon invasive ventilation under Neurally Adjusted ventilatory Assist
Interventions
Non invasive ventilation under Neurally adjusted Ventilatory Assist
Eligibility Criteria
You may qualify if:
- Patients admitted to the ICU and treated with Non invasive ventilation for acute respiratory failure of any origin
You may not qualify if:
- severe hypoxemia requiring an FIO2\>0.6
- hemodynamic instability
- known oesophageal problem
- active upper gastro-intestinal bleeding
- any other contraindication to the insertion of a naso-gastric tube
- impaired consciousness or absence of patient cooperation
- facial or laryngeal lesions contraindicating the use of NIV
- poor short term prognosis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital, Genevalead
- University Hospital St Luc, Brusselscollaborator
- University Hospital Sart Tilman, Liegecollaborator
- University of Lausanne Hospitalscollaborator
- Notre Dame de Grace Hospital, Gosseliescollaborator
Study Sites (4)
St Luc University hospital
Brussels, Belgium
Bernard Lambermont
Liège, Belgium
HUG, University Hospital
Geneva, 1211, Switzerland
CHUV University hospital of Lausanne
Lausanne, 1011, Switzerland
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Didier Tassaux, MD
HUG, University hospital Geneva
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
February 23, 2010
First Posted
February 24, 2010
Study Start
July 1, 2010
Primary Completion
December 1, 2010
Study Completion
December 1, 2011
Last Updated
September 21, 2012
Record last verified: 2010-01